The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 10, 2018
Filed:
Apr. 29, 2016
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Marc Hubert Mercken, Turnhout, BE;
Marc Maria Pierre Vandermeeren, Geel, BE;
Assignee:
JANSSEN PHARMACEUTICA NV, , BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61K 49/00 (2006.01); A61K 49/16 (2006.01); C07K 16/00 (2006.01); C12P 21/08 (2006.01); G01N 33/53 (2006.01); G01N 33/68 (2006.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); C07K 16/18 (2013.01); C07K 2317/34 (2013.01); G01N 2333/4709 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/52 (2013.01);
Abstract
This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta_11 N-terminal site, i.e. Aβ11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices.
Quick Actions:
Mercken, Marc. (2018). N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses (U.S. Patent No. 9939452). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9939452
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile